2003
DOI: 10.1186/cc1996
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Studies on head injury-induced pituitary dysfunction are limited in number and conflicting results have been reported. To further clarify this issue, 29 consecutive patients (24 males), with severe (n = 21) or moderate (n = 8) head trauma, having a mean age of 37 ± 17 years were investigated in the immediate post-trauma period. All patients required mechanical ventilatory support for 8-55 days and were enrolled in the study within a few days before ICU discharge. Basal hormonal assessment included measurement … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Using progressive in vitro hemodilutions (30% and 60%), Jamnicki [23] assessed the effects of different HES preparations (HES 200/0.5 and HES 130/0.4) on conventional TEG data, and found that the two solutions affect in vitro coagulation to the same degree (r and k increased; MA and α angle decreased progressively). However, Lochbühler [24] found no clinically significant changes in platelet count, prothrombin time, and activated partial thromboplastin time after HES 130/0.4 infusion in neonates and infants. Chong Sung [25] showed that administration of 10 mL · kg −1 HES 130/0.4 to children undergoing cardiac surgery does not cause more bleeding or increase transfusion requirements compared with FFP infusion.…”
Section: Discussionmentioning
confidence: 99%
“…Using progressive in vitro hemodilutions (30% and 60%), Jamnicki [23] assessed the effects of different HES preparations (HES 200/0.5 and HES 130/0.4) on conventional TEG data, and found that the two solutions affect in vitro coagulation to the same degree (r and k increased; MA and α angle decreased progressively). However, Lochbühler [24] found no clinically significant changes in platelet count, prothrombin time, and activated partial thromboplastin time after HES 130/0.4 infusion in neonates and infants. Chong Sung [25] showed that administration of 10 mL · kg −1 HES 130/0.4 to children undergoing cardiac surgery does not cause more bleeding or increase transfusion requirements compared with FFP infusion.…”
Section: Discussionmentioning
confidence: 99%